nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—PIK3CA—esophageal cancer	0.447	0.656	CbGaD
Caffeine—CYP1B1—esophageal cancer	0.182	0.267	CbGaD
Caffeine—ABCB1—esophageal cancer	0.0522	0.0766	CbGaD
Caffeine—RYR1—larynx—esophageal cancer	0.00961	0.114	CbGeAlD
Caffeine—Necrotising enterocolitis neonatal—Capecitabine—esophageal cancer	0.006	0.139	CcSEcCtD
Caffeine—Necrotizing enterocolitis—Capecitabine—esophageal cancer	0.006	0.139	CcSEcCtD
Caffeine—Necrotising colitis—Capecitabine—esophageal cancer	0.00491	0.114	CcSEcCtD
Caffeine—Ca++ increased—Capecitabine—esophageal cancer	0.00451	0.105	CcSEcCtD
Caffeine—PIK3CB—exocrine gland—esophageal cancer	0.00403	0.0479	CbGeAlD
Caffeine—PIK3CA—exocrine gland—esophageal cancer	0.00399	0.0474	CbGeAlD
Caffeine—PIK3CD—neck—esophageal cancer	0.00295	0.0351	CbGeAlD
Caffeine—PIK3CB—neck—esophageal cancer	0.00258	0.0306	CbGeAlD
Caffeine—PIK3CA—neck—esophageal cancer	0.00255	0.0303	CbGeAlD
Caffeine—ATM—epithelium—esophageal cancer	0.00227	0.0269	CbGeAlD
Caffeine—PRKDC—bronchus—esophageal cancer	0.00211	0.0251	CbGeAlD
Caffeine—PRKDC—smooth muscle tissue—esophageal cancer	0.00206	0.0245	CbGeAlD
Caffeine—PIK3CD—epithelium—esophageal cancer	0.00201	0.0239	CbGeAlD
Caffeine—PIK3CD—bronchus—esophageal cancer	0.00198	0.0235	CbGeAlD
Caffeine—PIK3CD—smooth muscle tissue—esophageal cancer	0.00194	0.023	CbGeAlD
Caffeine—PRKDC—trachea—esophageal cancer	0.00189	0.0225	CbGeAlD
Caffeine—PIK3CB—epithelium—esophageal cancer	0.00175	0.0208	CbGeAlD
Caffeine—PIK3CA—epithelium—esophageal cancer	0.00173	0.0206	CbGeAlD
Caffeine—PIK3CB—bronchus—esophageal cancer	0.00173	0.0205	CbGeAlD
Caffeine—ATM—digestive system—esophageal cancer	0.00172	0.0205	CbGeAlD
Caffeine—PIK3CA—bronchus—esophageal cancer	0.00171	0.0203	CbGeAlD
Caffeine—PIK3CB—smooth muscle tissue—esophageal cancer	0.00169	0.0201	CbGeAlD
Caffeine—RYR1—smooth muscle tissue—esophageal cancer	0.00167	0.0199	CbGeAlD
Caffeine—PIK3CA—smooth muscle tissue—esophageal cancer	0.00167	0.0199	CbGeAlD
Caffeine—Oxtriphylline—PDE4D—esophageal cancer	0.00159	0.353	CrCbGaD
Caffeine—PIK3CB—trachea—esophageal cancer	0.00155	0.0184	CbGeAlD
Caffeine—PIK3CD—digestive system—esophageal cancer	0.00153	0.0182	CbGeAlD
Caffeine—ATM—lung—esophageal cancer	0.00144	0.0171	CbGeAlD
Caffeine—PRKDC—lung—esophageal cancer	0.00136	0.0162	CbGeAlD
Caffeine—Dyphylline—PDE4D—esophageal cancer	0.00136	0.3	CrCbGaD
Caffeine—PIK3CB—digestive system—esophageal cancer	0.00133	0.0158	CbGeAlD
Caffeine—PIK3CA—digestive system—esophageal cancer	0.00132	0.0157	CbGeAlD
Caffeine—PIK3CD—lung—esophageal cancer	0.00128	0.0152	CbGeAlD
Caffeine—ADORA2B—bronchus—esophageal cancer	0.00126	0.0149	CbGeAlD
Caffeine—ADORA2B—smooth muscle tissue—esophageal cancer	0.00123	0.0146	CbGeAlD
Caffeine—ADORA2B—trachea—esophageal cancer	0.00113	0.0134	CbGeAlD
Caffeine—PIK3CB—lung—esophageal cancer	0.00111	0.0132	CbGeAlD
Caffeine—PIK3CA—lung—esophageal cancer	0.0011	0.0131	CbGeAlD
Caffeine—ATM—lymph node—esophageal cancer	0.000984	0.0117	CbGeAlD
Caffeine—Impaired healing—Methotrexate—esophageal cancer	0.000974	0.0226	CcSEcCtD
Caffeine—Theophylline—PDE4D—esophageal cancer	0.000966	0.214	CrCbGaD
Caffeine—PRKDC—lymph node—esophageal cancer	0.000931	0.0111	CbGeAlD
Caffeine—Infection—Carboplatin—esophageal cancer	0.000928	0.0215	CcSEcCtD
Caffeine—PIK3CD—lymph node—esophageal cancer	0.000873	0.0104	CbGeAlD
Caffeine—Haemoglobin decreased—Capecitabine—esophageal cancer	0.000823	0.0191	CcSEcCtD
Caffeine—Hypercalcaemia—Capecitabine—esophageal cancer	0.000815	0.0189	CcSEcCtD
Caffeine—ADORA2B—lung—esophageal cancer	0.000811	0.00964	CbGeAlD
Caffeine—PIK3CB—lymph node—esophageal cancer	0.000762	0.00905	CbGeAlD
Caffeine—PIK3CA—lymph node—esophageal cancer	0.000754	0.00896	CbGeAlD
Caffeine—PDE4B—bronchus—esophageal cancer	0.000668	0.00794	CbGeAlD
Caffeine—Deafness—Cisplatin—esophageal cancer	0.000623	0.0145	CcSEcCtD
Caffeine—Theophylline—CYP1B1—esophageal cancer	0.000601	0.133	CrCbGaD
Caffeine—PDE4B—trachea—esophageal cancer	0.0006	0.00713	CbGeAlD
Caffeine—ADORA1—lung—esophageal cancer	0.000582	0.00692	CbGeAlD
Caffeine—CYP1B1—smooth muscle tissue—esophageal cancer	0.00056	0.00666	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000557	0.0129	CcSEcCtD
Caffeine—Irritability—Cisplatin—esophageal cancer	0.000532	0.0123	CcSEcCtD
Caffeine—Blood creatinine increased—Cisplatin—esophageal cancer	0.000522	0.0121	CcSEcCtD
Caffeine—Urine output increased—Capecitabine—esophageal cancer	0.000512	0.0119	CcSEcCtD
Caffeine—Sepsis—Capecitabine—esophageal cancer	0.000491	0.0114	CcSEcCtD
Caffeine—Deafness—Capecitabine—esophageal cancer	0.000459	0.0107	CcSEcCtD
Caffeine—CYP1B1—digestive system—esophageal cancer	0.000442	0.00526	CbGeAlD
Caffeine—PDE4B—lung—esophageal cancer	0.000431	0.00512	CbGeAlD
Caffeine—Renal failure—Cisplatin—esophageal cancer	0.000422	0.0098	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000411	0.00953	CcSEcCtD
Caffeine—CYP1A1—epithelium—esophageal cancer	0.000411	0.00488	CbGeAlD
Caffeine—CYP1A1—bronchus—esophageal cancer	0.000405	0.00481	CbGeAlD
Caffeine—ADORA1—lymph node—esophageal cancer	0.000398	0.00473	CbGeAlD
Caffeine—Irritability—Capecitabine—esophageal cancer	0.000392	0.0091	CcSEcCtD
Caffeine—Blood creatinine increased—Capecitabine—esophageal cancer	0.000385	0.00893	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—esophageal cancer	0.000381	0.00884	CcSEcCtD
Caffeine—Dry skin—Capecitabine—esophageal cancer	0.000377	0.00874	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—esophageal cancer	0.000375	0.0087	CcSEcCtD
Caffeine—CYP1B1—lung—esophageal cancer	0.000369	0.00439	CbGeAlD
Caffeine—Sepsis—Methotrexate—esophageal cancer	0.000366	0.00848	CcSEcCtD
Caffeine—Gastritis—Capecitabine—esophageal cancer	0.000364	0.00844	CcSEcCtD
Caffeine—CYP1A1—trachea—esophageal cancer	0.000363	0.00432	CbGeAlD
Caffeine—Cardiac disorder—Cisplatin—esophageal cancer	0.000358	0.0083	CcSEcCtD
Caffeine—Immune system disorder—Cisplatin—esophageal cancer	0.000348	0.00808	CcSEcCtD
Caffeine—Malnutrition—Cisplatin—esophageal cancer	0.000336	0.00779	CcSEcCtD
Caffeine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00032	0.00743	CcSEcCtD
Caffeine—CYP1A2—digestive system—esophageal cancer	0.000317	0.00377	CbGeAlD
Caffeine—Infestation—Capecitabine—esophageal cancer	0.000317	0.00735	CcSEcCtD
Caffeine—Infestation NOS—Capecitabine—esophageal cancer	0.000317	0.00735	CcSEcCtD
Caffeine—CYP1A1—digestive system—esophageal cancer	0.000313	0.00371	CbGeAlD
Caffeine—Renal failure—Capecitabine—esophageal cancer	0.000311	0.00722	CcSEcCtD
Caffeine—CYP3A5—digestive system—esophageal cancer	0.000306	0.00363	CbGeAlD
Caffeine—CYP2C9—digestive system—esophageal cancer	0.000301	0.00357	CbGeAlD
Caffeine—PDE4B—lymph node—esophageal cancer	0.000295	0.0035	CbGeAlD
Caffeine—Irritability—Methotrexate—esophageal cancer	0.000292	0.00677	CcSEcCtD
Caffeine—Convulsion—Cisplatin—esophageal cancer	0.000291	0.00675	CcSEcCtD
Caffeine—Haemoglobin—Capecitabine—esophageal cancer	0.000286	0.00663	CcSEcCtD
Caffeine—CYP2E1—digestive system—esophageal cancer	0.000285	0.00339	CbGeAlD
Caffeine—Haemorrhage—Capecitabine—esophageal cancer	0.000284	0.00659	CcSEcCtD
Caffeine—Infection—Cisplatin—esophageal cancer	0.000272	0.00631	CcSEcCtD
Caffeine—Nervous system disorder—Cisplatin—esophageal cancer	0.000269	0.00623	CcSEcCtD
Caffeine—Tachycardia—Cisplatin—esophageal cancer	0.000267	0.0062	CcSEcCtD
Caffeine—Skin disorder—Cisplatin—esophageal cancer	0.000266	0.00617	CcSEcCtD
Caffeine—CYP1A2—lung—esophageal cancer	0.000265	0.00315	CbGeAlD
Caffeine—Cardiac disorder—Capecitabine—esophageal cancer	0.000264	0.00612	CcSEcCtD
Caffeine—CYP1A1—lung—esophageal cancer	0.000261	0.0031	CbGeAlD
Caffeine—Immune system disorder—Capecitabine—esophageal cancer	0.000257	0.00596	CcSEcCtD
Caffeine—CYP3A5—lung—esophageal cancer	0.000255	0.00303	CbGeAlD
Caffeine—CYP1B1—lymph node—esophageal cancer	0.000253	0.003	CbGeAlD
Caffeine—Malnutrition—Capecitabine—esophageal cancer	0.000247	0.00574	CcSEcCtD
Caffeine—Dyspnoea—Cisplatin—esophageal cancer	0.000244	0.00567	CcSEcCtD
Caffeine—CYP2E1—lung—esophageal cancer	0.000238	0.00283	CbGeAlD
Caffeine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000237	0.00549	CcSEcCtD
Caffeine—Infestation—Methotrexate—esophageal cancer	0.000236	0.00547	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—esophageal cancer	0.000236	0.00547	CcSEcCtD
Caffeine—Renal failure—Methotrexate—esophageal cancer	0.000232	0.00538	CcSEcCtD
Caffeine—CYP3A4—digestive system—esophageal cancer	0.000229	0.00273	CbGeAlD
Caffeine—CYP2D6—digestive system—esophageal cancer	0.000226	0.00268	CbGeAlD
Caffeine—Hypertension—Capecitabine—esophageal cancer	0.000214	0.00496	CcSEcCtD
Caffeine—ABCB1—epithelium—esophageal cancer	0.000213	0.00254	CbGeAlD
Caffeine—Haemoglobin—Methotrexate—esophageal cancer	0.000213	0.00493	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—esophageal cancer	0.000212	0.00491	CcSEcCtD
Caffeine—Hypersensitivity—Cisplatin—esophageal cancer	0.000202	0.00468	CcSEcCtD
Caffeine—Infection—Capecitabine—esophageal cancer	0.000201	0.00465	CcSEcCtD
Caffeine—Nervous system disorder—Capecitabine—esophageal cancer	0.000198	0.00459	CcSEcCtD
Caffeine—Tachycardia—Capecitabine—esophageal cancer	0.000197	0.00457	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—esophageal cancer	0.000196	0.00456	CcSEcCtD
Caffeine—Skin disorder—Capecitabine—esophageal cancer	0.000196	0.00455	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—esophageal cancer	0.000191	0.00443	CcSEcCtD
Caffeine—ABCB1—trachea—esophageal cancer	0.000189	0.00224	CbGeAlD
Caffeine—Malnutrition—Methotrexate—esophageal cancer	0.000184	0.00427	CcSEcCtD
Caffeine—Dyspnoea—Capecitabine—esophageal cancer	0.00018	0.00418	CcSEcCtD
Caffeine—CYP1A1—lymph node—esophageal cancer	0.000179	0.00212	CbGeAlD
Caffeine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000174	0.00404	CcSEcCtD
Caffeine—Rash—Cisplatin—esophageal cancer	0.000173	0.00401	CcSEcCtD
Caffeine—Dermatitis—Cisplatin—esophageal cancer	0.000173	0.004	CcSEcCtD
Caffeine—ABCB1—digestive system—esophageal cancer	0.000162	0.00193	CbGeAlD
Caffeine—Convulsion—Methotrexate—esophageal cancer	0.00016	0.0037	CcSEcCtD
Caffeine—Infection—Methotrexate—esophageal cancer	0.000149	0.00346	CcSEcCtD
Caffeine—Hypersensitivity—Capecitabine—esophageal cancer	0.000149	0.00345	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—esophageal cancer	0.000147	0.00342	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—esophageal cancer	0.000146	0.00339	CcSEcCtD
Caffeine—ABCB1—lung—esophageal cancer	0.000136	0.00161	CbGeAlD
Caffeine—Dyspnoea—Methotrexate—esophageal cancer	0.000134	0.00311	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00013	0.00301	CcSEcCtD
Caffeine—Rash—Capecitabine—esophageal cancer	0.000127	0.00295	CcSEcCtD
Caffeine—Dermatitis—Capecitabine—esophageal cancer	0.000127	0.00295	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—esophageal cancer	0.000111	0.00257	CcSEcCtD
Caffeine—Rash—Methotrexate—esophageal cancer	9.48e-05	0.0022	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—esophageal cancer	9.47e-05	0.0022	CcSEcCtD
Caffeine—ABCB1—lymph node—esophageal cancer	9.27e-05	0.0011	CbGeAlD
Caffeine—ADORA2B—Signaling Pathways—CCND1—esophageal cancer	4.43e-06	2.37e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.42e-06	2.37e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CRABP1—esophageal cancer	4.39e-06	2.36e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ENO1—esophageal cancer	4.37e-06	2.34e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS1—esophageal cancer	4.37e-06	2.34e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—PIK3CA—esophageal cancer	4.34e-06	2.33e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALDOB—esophageal cancer	4.34e-06	2.33e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—PIK3CA—esophageal cancer	4.34e-06	2.33e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NOTCH1—esophageal cancer	4.33e-06	2.32e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CDKN1A—esophageal cancer	4.32e-06	2.32e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PSME1—esophageal cancer	4.31e-06	2.31e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PSME2—esophageal cancer	4.31e-06	2.31e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALDOB—esophageal cancer	4.3e-06	2.31e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—PIK3CA—esophageal cancer	4.29e-06	2.3e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CDKN1A—esophageal cancer	4.28e-06	2.3e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.28e-06	2.29e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTT1—esophageal cancer	4.28e-06	2.29e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—EGFR—esophageal cancer	4.27e-06	2.29e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NOS3—esophageal cancer	4.26e-06	2.28e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—ERBB2—esophageal cancer	4.26e-06	2.28e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TYMP—esophageal cancer	4.24e-06	2.27e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	4.23e-06	2.27e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—ERBB2—esophageal cancer	4.21e-06	2.26e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.21e-06	2.26e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CA2—esophageal cancer	4.2e-06	2.25e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GNG7—esophageal cancer	4.18e-06	2.24e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GAPDH—esophageal cancer	4.18e-06	2.24e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PIK3CA—esophageal cancer	4.17e-06	2.24e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GAPDH—esophageal cancer	4.14e-06	2.22e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CRABP1—esophageal cancer	4.14e-06	2.22e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	4.12e-06	2.21e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EP300—esophageal cancer	4.11e-06	2.2e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MYC—esophageal cancer	4.11e-06	2.2e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CRABP1—esophageal cancer	4.1e-06	2.2e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EP300—esophageal cancer	4.08e-06	2.18e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MYC—esophageal cancer	4.03e-06	2.16e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—EGFR—esophageal cancer	4.02e-06	2.16e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALOX15—esophageal cancer	4.02e-06	2.15e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS1—esophageal cancer	4.01e-06	2.15e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ENO1—esophageal cancer	4.01e-06	2.15e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—ERBB2—esophageal cancer	3.99e-06	2.14e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PSME2—esophageal cancer	3.95e-06	2.12e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PSME1—esophageal cancer	3.95e-06	2.12e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—EGFR—esophageal cancer	3.95e-06	2.11e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	3.94e-06	2.11e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GNG7—esophageal cancer	3.94e-06	2.11e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	3.93e-06	2.11e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CREBBP—esophageal cancer	3.93e-06	2.11e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ALDH2—esophageal cancer	3.92e-06	2.1e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.91e-06	2.09e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ADH7—esophageal cancer	3.91e-06	2.09e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GNG7—esophageal cancer	3.9e-06	2.09e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—EP300—esophageal cancer	3.88e-06	2.08e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—EGFR—esophageal cancer	3.86e-06	2.07e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TPI1—esophageal cancer	3.83e-06	2.06e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTO1—esophageal cancer	3.83e-06	2.06e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCND1—esophageal cancer	3.76e-06	2.02e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.76e-06	2.02e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.76e-06	2.01e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTT1—esophageal cancer	3.72e-06	2e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCND1—esophageal cancer	3.72e-06	1.99e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CYP1B1—esophageal cancer	3.72e-06	1.99e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	3.71e-06	1.99e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	3.7e-06	1.98e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALDH2—esophageal cancer	3.69e-06	1.98e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	3.69e-06	1.98e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.68e-06	1.97e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALDOB—esophageal cancer	3.68e-06	1.97e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALDH2—esophageal cancer	3.66e-06	1.96e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CDKN1A—esophageal cancer	3.64e-06	1.95e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PIK3CA—esophageal cancer	3.64e-06	1.95e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CDKN1A—esophageal cancer	3.6e-06	1.93e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MYC—esophageal cancer	3.58e-06	1.92e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MYC—esophageal cancer	3.55e-06	1.9e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GAPDH—esophageal cancer	3.54e-06	1.9e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCND1—esophageal cancer	3.52e-06	1.89e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NOS3—esophageal cancer	3.52e-06	1.89e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTT1—esophageal cancer	3.51e-06	1.88e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CRABP1—esophageal cancer	3.51e-06	1.88e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EGFR—esophageal cancer	3.51e-06	1.88e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CYP19A1—esophageal cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PIK3CA—esophageal cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS1—esophageal cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ENO1—esophageal cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.49e-06	1.87e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTT1—esophageal cancer	3.48e-06	1.87e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EGFR—esophageal cancer	3.47e-06	1.86e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	3.47e-06	1.86e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EP300—esophageal cancer	3.47e-06	1.86e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.45e-06	1.85e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	3.44e-06	1.84e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PSME2—esophageal cancer	3.44e-06	1.84e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PSME1—esophageal cancer	3.44e-06	1.84e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.43e-06	1.84e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.42e-06	1.84e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EP300—esophageal cancer	3.42e-06	1.84e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	3.41e-06	1.83e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CDKN1A—esophageal cancer	3.41e-06	1.83e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—HMOX1—esophageal cancer	3.38e-06	1.81e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—esophageal cancer	3.38e-06	1.81e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—HMOX1—esophageal cancer	3.37e-06	1.81e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—PIK3CA—esophageal cancer	3.35e-06	1.8e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GNG7—esophageal cancer	3.34e-06	1.79e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—CREBBP—esophageal cancer	3.32e-06	1.78e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—ERBB2—esophageal cancer	3.29e-06	1.76e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS1—esophageal cancer	3.29e-06	1.76e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ENO1—esophageal cancer	3.29e-06	1.76e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMP—esophageal cancer	3.27e-06	1.75e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS1—esophageal cancer	3.26e-06	1.75e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ENO1—esophageal cancer	3.26e-06	1.75e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ABCB1—esophageal cancer	3.25e-06	1.74e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EP300—esophageal cancer	3.24e-06	1.74e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PSME2—esophageal cancer	3.24e-06	1.74e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PSME1—esophageal cancer	3.24e-06	1.74e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ABCB1—esophageal cancer	3.24e-06	1.74e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PSME2—esophageal cancer	3.21e-06	1.72e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PSME1—esophageal cancer	3.21e-06	1.72e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	3.2e-06	1.72e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—HMOX1—esophageal cancer	3.19e-06	1.71e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.18e-06	1.71e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.13e-06	1.68e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALDH2—esophageal cancer	3.13e-06	1.68e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALOX15—esophageal cancer	3.1e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCB1—esophageal cancer	3.06e-06	1.64e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PIK3CA—esophageal cancer	3.04e-06	1.63e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—esophageal cancer	3.02e-06	1.62e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PIK3CA—esophageal cancer	3.01e-06	1.62e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.99e-06	1.61e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—esophageal cancer	2.98e-06	1.6e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.97e-06	1.59e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—NOS3—esophageal cancer	2.97e-06	1.59e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.97e-06	1.59e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.96e-06	1.59e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.96e-06	1.59e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—esophageal cancer	2.95e-06	1.58e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—esophageal cancer	2.94e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.94e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.93e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—HMOX1—esophageal cancer	2.92e-06	1.57e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—esophageal cancer	2.92e-06	1.56e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—esophageal cancer	2.92e-06	1.56e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—esophageal cancer	2.91e-06	1.56e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.87e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.84e-06	1.52e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—esophageal cancer	2.82e-06	1.51e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1A—esophageal cancer	2.81e-06	1.51e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.81e-06	1.5e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—esophageal cancer	2.81e-06	1.5e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.8e-06	1.5e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.79e-06	1.5e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS1—esophageal cancer	2.79e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO1—esophageal cancer	2.79e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.77e-06	1.49e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—esophageal cancer	2.76e-06	1.48e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PSME1—esophageal cancer	2.75e-06	1.47e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PSME2—esophageal cancer	2.75e-06	1.47e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.73e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—esophageal cancer	2.72e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.71e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—NOS3—esophageal cancer	2.68e-06	1.44e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EP300—esophageal cancer	2.68e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.63e-06	1.41e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	2.61e-06	1.4e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNG7—esophageal cancer	2.57e-06	1.38e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—esophageal cancer	2.56e-06	1.37e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HMOX1—esophageal cancer	2.55e-06	1.36e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—esophageal cancer	2.53e-06	1.36e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—esophageal cancer	2.48e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.45e-06	1.31e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—esophageal cancer	2.45e-06	1.31e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.41e-06	1.29e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.4e-06	1.29e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.4e-06	1.29e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.38e-06	1.28e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.37e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.33e-06	1.25e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—esophageal cancer	2.33e-06	1.25e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—esophageal cancer	2.32e-06	1.24e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.31e-06	1.24e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—esophageal cancer	2.3e-06	1.23e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.29e-06	1.23e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.28e-06	1.22e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—esophageal cancer	2.28e-06	1.22e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.27e-06	1.22e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—EP300—esophageal cancer	2.26e-06	1.21e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.23e-06	1.19e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CREBBP—esophageal cancer	2.17e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CREBBP—esophageal cancer	2.16e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO1—esophageal cancer	2.15e-06	1.15e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.15e-06	1.15e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.12e-06	1.14e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PSME2—esophageal cancer	2.12e-06	1.14e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PSME1—esophageal cancer	2.12e-06	1.14e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CREBBP—esophageal cancer	2.04e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—EP300—esophageal cancer	2.04e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HMOX1—esophageal cancer	2.03e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.99e-06	1.07e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—esophageal cancer	1.98e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.95e-06	1.05e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—NOS3—esophageal cancer	1.94e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—NOS3—esophageal cancer	1.94e-06	1.04e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—esophageal cancer	1.91e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.87e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NOS3—esophageal cancer	1.83e-06	9.82e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.83e-06	9.8e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—esophageal cancer	1.78e-06	9.52e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.77e-06	9.5e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.73e-06	9.25e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.72e-06	9.22e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NOS3—esophageal cancer	1.68e-06	9e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—esophageal cancer	1.67e-06	8.98e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—esophageal cancer	1.67e-06	8.97e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CREBBP—esophageal cancer	1.63e-06	8.76e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.57e-06	8.41e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.54e-06	8.25e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.54e-06	8.23e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.53e-06	8.18e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.51e-06	8.09e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.51e-06	8.07e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—EP300—esophageal cancer	1.48e-06	7.92e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.48e-06	7.91e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—EP300—esophageal cancer	1.47e-06	7.9e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NOS3—esophageal cancer	1.46e-06	7.84e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—EP300—esophageal cancer	1.39e-06	7.47e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NOS3—esophageal cancer	1.38e-06	7.39e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NOS3—esophageal cancer	1.37e-06	7.32e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.34e-06	7.17e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.3e-06	6.99e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—EP300—esophageal cancer	1.28e-06	6.85e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.26e-06	6.76e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.25e-06	6.7e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NOS3—esophageal cancer	1.17e-06	6.26e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—EP300—esophageal cancer	1.11e-06	5.96e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	1.09e-06	5.86e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.09e-06	5.85e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.07e-06	5.72e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—EP300—esophageal cancer	1.05e-06	5.62e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—EP300—esophageal cancer	1.04e-06	5.57e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—esophageal cancer	1.03e-06	5.52e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.01e-06	5.39e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	9.45e-07	5.06e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NOS3—esophageal cancer	9.01e-07	4.83e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—EP300—esophageal cancer	8.88e-07	4.76e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—esophageal cancer	8.24e-07	4.42e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—esophageal cancer	8.23e-07	4.41e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	7.75e-07	4.16e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	7.69e-07	4.12e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—EP300—esophageal cancer	6.85e-07	3.67e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	6.57e-07	3.52e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	5.07e-07	2.72e-06	CbGpPWpGaD
